Voyager Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $351.3M
Liabilities Breakdown FY2023
Total Liabilities: $115.0M
Asset Breakdown
Total Assets: $351.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $68.8M | 19.6% |
| Accounts Receivable | $80.2M | 22.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $16.5M | 4.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $185.8M | 52.9% |
Liabilities Breakdown
Total Liabilities: $115.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.6M | 1.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $113.4M | 98.6% |